Những người này rất chắc chắn. Mọi thứ minh bạch, báo cáo đến đều đặn, và họ làm đúng những gì đã nói. Không có thông tin ẩn, tôi đã kiểm tra
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity | Seeking AlphaAmazon senior cloud executive departs after 18 yearsWhy Jim Cramer is shocked by Citi's against-the-grain praise of Microsoft's CopilotFranklin Federal Tax-Free Income Fund Q2 2026 Commentary (MUTF:FAFTX) | Seeking AlphaFractured Iran Makes Hormuz Flare-Ups Inevitable, Is China The Key? (SPY) | Seeking Alpha
Business
The tech trade has grown "tired" despite fundamentally positive indicators for the AI infrastructure cycle, said Gene Munster, co-founder of Deepwater Asset Management. In an interview with CNBC, Munster emphasized that recent market pullbacks are driven by psychology rather than deteriorating The…
Business
Compass Therapeutics, Inc. (CMPX) is a pre-revenue oncology company that focuses on developing bispecific antibodies. The stock is currently trading at around $2.27, which is about 50% lower than what it was trading at roughly 3 months I started my investing journey at age 18, and over the years, I…
Chưa có bài viết nào
Các bài viết sẽ xuất hiện ở đây ngay sau khi được đăng tải.
Edenex. Lựa chọn khôn ngoan
